Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
6 of 8 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both L-Lysine and Omega-3 have evidence — compare verdict strength side-by-side.
500-3000mg daily; higher for active outbreaks
Empty stomach for better absorption, Divided doses throughout day, Away from high-arginine foods
L-Lysine HCl (capsules or powder)
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
2-4 weeks prevention; acute treatment faster
4-8 weeks
Ongoing
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview
Nutrients (2020) · Systematic review · n=55
Oral ingestion of most individual AAs induced an insulin response, but did not alter glucose concentrations in healthy participants.
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis "Nutra NMA SCZ"
Molecular psychiatry (2025) · Meta analysis · n=50
Change (Standardized Mean Difference = SMD) in total symptomatology and acceptability (Risk Ratio = RR) were co-primary outcomes.
A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study
Nutrients (2024) · Rct
Despite no significance regarding the distribution of Pfirrmann grade changes (improvement, no change, worsening; p = 0.259), in the supplement group, one patient achieved a three-grade improvement, and worsening of Pfirrmann grades were only detected in the placebo group (9.1%).
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Safety profile based on systematic review of 71 studies (n=2619). Risk analysis showed no statistically significant increase in GI symptoms (RR 1.02, 95% CI 0.96-1.07, p=0.49). Adverse events were mainly subjective GI symptoms. Short-term use up to 6g appears safe.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 5.5/10) and wins in 2 of 3 categories.
For reduce anxiety & stress, Omega-3 has a higher relevance score (65 vs 52).
No known interactions between L-Lysine and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.